Inhibition of human and duck hepatitis B virus by 2′,3′-dideoxy-3′-fluoroguanosine in vitro
- 1 January 1998
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 37 (1) , 57-66
- https://doi.org/10.1016/s0166-3542(97)00057-0
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replicationAntiviral Research, 1992
- Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates.Proceedings of the National Academy of Sciences, 1992
- A cell culture assay for compounds which inhibit hepatitis B virus replicationAntiviral Research, 1991
- Detection and Quantification of Human Immunodeficiency Virus RNA in Patient Serum by Use of the Polymerase Chain ReactionThe Journal of Infectious Diseases, 1991
- Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B Virus in vitro using conventional antiviral agents and supercoiled‐DNA active compoundsJournal of Medical Virology, 1990
- Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucksAntimicrobial Agents and Chemotherapy, 1990
- Inhibition of RNA- and DNA-dependent duck hepatitis B virus DNA polymerase activity by nucleoside and pyrophosphate analogsAntiviral Research, 1989
- Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay.Proceedings of the National Academy of Sciences, 1989
- Enhanced In Vitro Inhibition of HIV-1 Replication by 3′-Fluoro-3′-deoxythymidine Compared to Several Other Nucleoside AnalogsAIDS Research and Human Retroviruses, 1988
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUSThe Lancet, 1981